In this video:
Dr Ajay Khopade, VP F&D, Sun Pharma
Topic: Making India an epicentre for FR&D
Key Highlights:
1) There is a lot of scope of India Pharma Inc to invest in innovative R&D. Incentives, grants, collaboration with academia will facilitate more investments in pharma R&D.
2) Eliminating duplications and redundancies from our regulations, harmonisation with global regulations is vital to make India an epicentre for FR&D.
3) We need a more robust IPR regime to build and sustain a conducive environment for R&D investments and make India a global pharma R&D hub
4) Invest in training and skilling programs for scientists to enhance India’s talent pool and facilitate cutting edge research in pharma